List of works by Gabriella Pagnan

An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells.

scientific article published on January 2007

Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells

scientific article published on 18 January 2007

Apoptosis of Human Neuroblastoma Cells Induced by Liposome-Encapsulated Fenretinide

CHL1 gene acts as a tumor suppressor in human neuroblastoma.

scientific article

Caspase-8 gene expression in neuroblastoma.

scientific article

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

scientific article published on 24 March 2010

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

scientific article

DNA damage or growth factor withdrawal does not evoke activation of MYB transcription factors in neuronal cancer cell lines

scientific article published on 01 January 2003

Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.

scientific article published on February 2000

Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells

scientific article

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

scientific article

Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region

scientific article published on 01 December 2002

Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients

scientific article published on 01 March 2002

Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE)

scientific article published on 01 January 2004

Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.

scientific article published on August 2004

Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.

scientific article

In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.

scientific article published in May 2003

Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion

scientific article published on 01 March 1997

Ligand-targeted liposomal therapies of neuroblastoma.

scientific article published on January 2007

Liposome-mediated therapy of neuroblastoma

scientific article published in January 2009

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

scientific article published on 05 August 2013

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

scientific article

Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation

scientific article published on November 1, 1992

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma

scientific article published on 9 August 2011

Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.

scientific article

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

scientific article published on October 2006

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response

scientific article

The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

scientific article published on 6 October 2014

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

scientific article published on 29 May 2015